Inicio › Colitis ulcerativa › Nueva York
Ensayos clínicos de Colitis ulcerativa en Nueva York
28 estudios sobre Colitis ulcerativa buscan participantes en Nueva York.
Ciudades en Nueva York
Texto oficial del estudio (inglés)
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-002, Albany
- Site US-016, Rochester
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 12 nov 2026 · NCT07845487Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- NYU Langone Hospital - Long Island, Mineola
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- y 1 más
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT03816345A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
- Columbia University Medical Center, New York
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 12 nov 2026 · NCT06636656Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- New York Gastroenterology Associates ( Site 0253), New York
ReclutandoFase 3
Todas las edades · Todos los sexos · Actualizado el 10 nov 2026 · NCT06651281LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Stony Brook University, Stony Brook
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 4 nov 2026 · NCT07415044Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Icahn School of Medicine at Mount Sinai, New York
- New York Gastroenterology Associates, New York
- Care Access - Yonkers, Yonkers
ReclutandoFase 3
Edades de 18 a 70 · Todos los sexos · Actualizado el 4 nov 2026 · NCT06937086LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Digestive Disease Medicine of Central New York, Utica
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 4 nov 2026 · NCT07186101Safety, Dosage, and Microbiome Engraftment Study of MGT-006 for Ulcerative Colitis (ROOT Study)
- NYU Langone Health, New York
ReclutandoFase 1/2
Edades de 18 a 75 · Todos los sexos · Actualizado el 3 nov 2026 · NCT07913347A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- New York Gastroenterology Associates, New York
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT07577856Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Xencor Investigative Site, Albany
- Xencor Investigative Site, Rochester
ReclutandoFase 1/2Se aceptan voluntarios sanos
Edades de 18 a 75 · Todos los sexos · Actualizado el 30 oct 2026 · NCT06619990A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Westchester Putnam Gastroenterology PC, Carmel
- Five Towns Gastroenterology, Cedarhurst
- IMIDeology, Elmhurst
- y 5 más
ReclutandoFase 4
Edades de 18 a 80 · Todos los sexos · Actualizado el 28 oct 2026 · NCT06581328A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
- Intercity Gastroenterology, Fresh Meadows
- University of Rochester - PARENT, Rochester
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 27 oct 2026 · NCT06979336Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- New York Gastroenterology Associates - Upper East Side /ID# 281767, New York
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 27 oct 2026 · NCT07697456A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 037, New York
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 27 oct 2026 · NCT07012395A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
- Fink Children's Ambulatory Care Center, New York
- Kimmel Pavilion - NYU Langone, New York
- NYU Grossman School of Medicine, New York
- y 4 más
ReclutandoFase 2
Edades de 2 a 11 · Todos los sexos · Actualizado el 26 oct 2026 · NCT07470879An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
- NYU Langone Health, New York
- Lenox Hill Hospital, Northwell Health, New York
ReclutandoEstudio observacional
Edades de 18 a 64 · Todos los sexos · Actualizado el 26 oct 2026 · NCT06398626Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
- State University of New York Upstate Medical University, Syracuse
Reclutando
Edades de 18 a 85 · Todos los sexos · Actualizado el 23 oct 2026 · NCT05987852An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- MedTraits NY - Site Number: 8400045, Maspeth
- Manhattan Clinical Research, LLC - Site Number: 8400069, New York
- NYU Langone Health - Site Number: 8400091, New York
- y 4 más
ReclutandoFase 3
Edades de 16 a 80 · Todos los sexos · Actualizado el 23 oct 2026 · NCT07184996A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Columbia University Medical Center, New York
ReclutandoFase 2/3
Edades de 2 a 17 · Todos los sexos · Actualizado el 20 oct 2026 · NCT05076175A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- MedTraits NY - Site Number: 8400045, Maspeth
- NYU Langone Health-Site Number: 8400091, New York
- Weill Cornell Medicine - NewYork-Presbyterian Hospital - Site Number: 8400040, New York
- y 2 más
ReclutandoFase 3
Edades de 16 a 80 · Todos los sexos · Actualizado el 16 oct 2026 · NCT07185009Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
- NYU Langone Health, New York
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 oct 2026 · NCT06750731A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- New York Presbyterian Hospital, New York
ReclutandoFase 3
Edades de 2 a 17 · Todos los sexos · Actualizado el 9 oct 2026 · NCT06405087A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Icahn School of Medicine at Mount Sinai, New York
ReclutandoFase 3
Edades de 2 a 19 · Todos los sexos · Actualizado el 7 oct 2026 · NCT04844606Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- Saratoga Schenectady Gastroenterology Associates, Burnt Hills
- NYU Langone Health, New York
- Cornell University, New York
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 7 ago 2026 · NCT05230173BOOM-IBD2 Pivotal Clinical Trial
- Northwell Health North Shore University Hospital, Manhasset
- Columbia University Irving Medical Center/New York Presbyterian Hospital, New York
Reclutando
Edades de 18 a 85 · Todos los sexos · Actualizado el 6 ago 2026 · NCT06571669Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- New York University, New York
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 ago 2026 · NCT07237516A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, New York
- Mirador Therapeutics Selected Site, Rochester
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 12 mar 2026 · NCT07113522Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis
- Bausch Health Site 006, The Bronx
ReclutandoFase 4
Edades de 5 a 17 · Todos los sexos · Actualizado el 16 sept 2025 · NCT04314375De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.